Henry Li

Title: Henry Li - Innovator in Tumor Immunology

Introduction

Henry Li is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of tumor immunology through his innovative research and patenting efforts. His work focuses on understanding immune responses in murine tumor models, which is crucial for developing effective cancer therapies.

Latest Patents

Henry Li holds a patent titled "Methods and compositions for assessing immune response in murine tumor models." This patent provides methods and compositions, including kits and microarrays, for assessing the immune response in a murine tumor model based on the expression of a gene panel that characterizes tumor immune interactions. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge in this area.

Career Highlights

Throughout his career, Henry Li has worked with prominent companies in the biotechnology sector. He has been associated with Crown Bioscience (Suzhou) Inc. and Crown Bioscience Inc., where he has contributed to various research initiatives aimed at improving cancer treatment methodologies.

Collaborations

Henry has collaborated with esteemed colleagues, including Jia Xue and Xiaobo Chen. These partnerships have enhanced his research capabilities and have led to significant advancements in the understanding of tumor immunology.

Conclusion

Henry Li's innovative work in assessing immune responses in murine tumor models highlights his dedication to cancer research. His contributions through patenting and collaboration with industry leaders position him as a key figure in the field of tumor immunology.